What happened in the Clinical Trial Data Stolen in Novo Nordisk HIPAA breach?

Clinical Trial Data Stolen in Novo Nordisk reported a HIPAA breach to the HHS Office for Civil Rights affecting 0 individuals. The breach involved Theft.

How many patients were affected by the Clinical Trial Data Stolen in Novo Nordisk data breach?

The exact number of affected patients has not been publicly disclosed by Clinical Trial Data Stolen in Novo Nordisk.

What type of breach did Clinical Trial Data Stolen in Novo Nordisk report?

Clinical Trial Data Stolen in Novo Nordisk reported a Theft incident. This was reported to the HHS Breach Portal on June 15, 2026.

Is my practice at risk for a similar HIPAA breach?

Healthcare practices face increasing cybersecurity threats. The most common breach types include hacking/IT incidents, unauthorized access, and theft. Get a free HIPAA Agent Compliance Score at hipaaagent.ai to assess your practice's security posture and identify vulnerabilities before they lead to a breach.

Medium Severity (Score: 5/10)

Clinical Trial Data Stolen in Novo Nordisk HIPAA Breach Report

Share:𝕏 f in

Breach Details

Entity

Clinical Trial Data Stolen in Novo Nordisk

Individuals Affected

Undisclosed

State

United States

Breach Type

Theft

Location

Not Disclosed

Date Reported

June 15, 2026

Entity Type

Healthcare Provider

Business Associate

Could this happen to your practice?

Find out where you stand with a free 83-tool vulnerability scan.

Free HIPAA Agent Compliance Score™Try Free for 7 Days

Summary

Novo Nordisk, the Danish pharmaceutical firm behind the GLP-1 weight loss drugs Ozempic and Wegovy, has experienced a cyberattack that […] The post Clinical Trial Data Stolen in Novo Nordisk Cyberattack appeared first on The HIPAA Journal.

Share:𝕏 f in

Source: This breach was reported to the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) Breach Portal. Data sourced from ocrportal.hhs.gov. Analysis and article generated by HIPAA Agent.